Abstract:Background Although surgical resection or amputation has been the mainstay of localized chondrosarcoma management for many decades, its efficacy in patients with metastatic chondrosarcoma remains unknown, and likewise we do not know whether there are any tumor-or patient-related factors associated with better survival after surgery for metastatic chondrosarcoma. Questions/purposes (1) Is resection of the primary tumor associated with improved survival in patients with metastatic chondrosarcoma? (2) Which subgroups of patients with chondrosarcoma benefit more from resection in terms of survival? Methods We identified 200 of 222 patients with metastatic chondrosarcoma in the Surveillance, Epidemiology, and End Results (SEER) database between 1988 and 2014 based on the exclusion criteria. Among those patients, 107 (53.5%) underwent primary tumor resection or amputation. Patient information, including demographics (patient age, gender, race, year of diagnosis), tumor characteristics (primary site, histologic subtype, tumor grade, tumor size), and treatment (record of operation and radiation), was collected and included in the study. Kaplan-Meier analyses, log-rank tests, competing risks framework, multivariable Cox regression modeling, and interaction tests were conducted to assess the association of primary tumor resection and survival in the overall cohort and subgroups. Results Resection of the primary tumor was associated with improved overall survival (hazard ratio [HR], 0.481; 95% confidence interval [CI], 0.340-0.680; p < 0.001) and cancer-specific survival (HR, 0.493; 95% CI, 0.343-0.709; p < 0.001) after controlling for confounding variables. After controlling further for age, histologic subtype, and grade, primary tumor resection was associated with a survival advantage in patients with conventional subtype and Grade II chondrosarcoma (conventional subtype: HR, 0.403; 95% CI, 0.260-0.623 for overall survival and HR, 0.396; 95% CI, 0.250-0.627 for cancer-specific survival). However, primary tumor resection was not associated with increased survival in patients with metastatic chondrosarcoma who had the dedifferentiated subtype and Grade III malignancy. Conclusions The present study demonstrates a possible favorable association between primary tumor resection and survival in some patients with metastatic chondrosarcoma at initial diagnosis. Specifically, patients with conventional subtypes and Grade II malignancies who underwent primary tumor resection had better survival compared with those patients who did not have primary tumor resection. Thus, there might be a benefit from primary tumor resection in these patients, but given the limitations of this database, further prospective studies or randomized trials are needed to confirm our findings. In the meantime, this information might be helpful to consider when discussing surgical options with patients who have conventional, Grade 2 metastatic chondrosarcoma at diagnosis. Level of Evidence Level III, therapeutic study.

Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer

Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?

Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis

Prognostic impact of primary tumour location after curative resection in Stage I–III colorectal cancer: a single-centre retrospective study

Superior survival in right-sided versus left-sided colon signet ring cell carcinoma

The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis

Different Anatomical Subsites of Colon Cancer and Mortality: A Population-Based Study

SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS)

Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer

Lymph Node Status and Its Impact on the Prognosis of Left‐sided and Right‐sided Colon Cancer: A SEER Population‐based Study

Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study

Comparison of Right-side and Left-side Colon Cancers Following Laparoscopic Radical Lymphadenectomy

The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer

Postoperative Local Recurrence of Colon Cancer

Subdivision of metastatic colorectal cancer for identifying patients who benefit more from primary tumor resection

Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study

Disparities in Survival for Right-Sided Vs. Left-Sided Colon Cancers in Young Patients: a Study Based on the Surveillance, Epidemiology, and End Results Database (1990-2014)

Incidence, Predictors and Prognostic Implications of Positive Circumferential Resection Margin in Colon Cancer: A Retrospective Study in a Chinese High-Volume Cancer Center.

Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer

Different Treatment Strategies and Molecular Features Between Right-Sided and Left-Sided Colon Cancers

Left-sided Primary Tumor is a Favorable Prognostic Factor for Metastatic Colorectal Cancer Patients Receiving Surgery